Zynerba Pharmaceuticals Reports Third Quarter 2018 Financial Results and Operational Highlights
DEVON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]